Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Accumulated Expenses (2020 - 2025)

IceCure Medical (ICCM) has disclosed Accumulated Expenses for 6 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 3.55% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, down 3.55% year-over-year, with the annual reading at $2.7 million for FY2025, 3.55% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $2.7 million at IceCure Medical, down from $2.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $2.9 million in Q4 2021, with the low at $554000.0 in Q4 2022.
  • Average Accumulated Expenses over 5 years is $1.9 million, with a median of $2.7 million recorded in 2025.
  • The sharpest move saw Accumulated Expenses plummeted 80.99% in 2022, then skyrocketed 337.62% in 2024.
  • Over 5 years, Accumulated Expenses stood at $2.9 million in 2021, then tumbled by 80.99% to $554000.0 in 2022, then rose by 13.72% to $630000.0 in 2023, then soared by 337.62% to $2.8 million in 2024, then dropped by 3.55% to $2.7 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $2.7 million, $2.8 million, and $630000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.